{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-119817","form_type":"8-K","ticker":"TELA","cik":"0001561921","company_name":"TELA Bio, Inc.","filed_at":"2021-09-27T23:59:59+00:00","discovered_at":"2026-05-14T18:04:18.584057+00:00","generated_at":"2026-06-29T01:16:21.206647+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"TELA Bio appoints Roberto Cuca as CFO and COO effective September 27, 2021","bullets":["Roberto Cuca appointed CFO and COO, effective 9/27/21; succeeds Megan Smeykal as principal financial officer.","Employment agreement: $425k base salary, 50% target bonus, and inducement option for 144k shares at $13.31.","Option vests 25% on 1st anniversary, 75% over 36 months; severance includes 9-12 months base salary.","Cuca previously CFO of OraSure Technologies (Jun 2018-Sep 2021) and Trevena (Sep 2013-May 2018).","Inducement grant complies with Nasdaq Rule 5635(c)(4)."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-119817","json":"https://secwatch.observer/filing/0001104659-21-119817.json","markdown":"https://secwatch.observer/filing/0001104659-21-119817.md","text":"https://secwatch.observer/filing/0001104659-21-119817.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1561921/000110465921119817/0001104659-21-119817-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1561921/000110465921119817/tm2128539d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T01:16:21.206647+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1f9b985b95","claim":"Megan Smeykal changed role as Vice President – Corporate Controller at TELA Bio, Inc..","evidence_excerpt":"Effective upon Mr. Cuca’s employment, Megan Smeykal, the Company’s Vice President – Corporate Controller, will cease performing the duties of the principal financial officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1561921/000110465921119817/0001104659-21-119817-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"will cease performing the duties"},{"label":"Role","value":"Vice President – Corporate Controller"}],"fact_type":"executive_change"},{"claim_id":"dcc837c688","claim":"Roberto Cuca was appointed as Chief Financial Officer and Chief Operating Officer at TELA Bio, Inc..","evidence_excerpt":"announced the appointment of Roberto Cuca as Chief Financial Officer and Chief Operating Officer of the Company, effective September 27, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1561921/000110465921119817/0001104659-21-119817-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer and Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}